Education
About Us
Working with TipRanks
Follow Us
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 2.23M | $ 2.52M | $ 3.53M | $ 3.93M |
| Gross Profit | $ 0.00 | $ -5.36M | $ -17.31M | $ 3.53M | $ 2.56M |
| Operating Income | $ -6.73T | $ -10.72M | $ -24.22M | $ -19.87M | $ -1.61M |
| EBITDA | $ -6.73T | $ -10.72M | $ -24.22M | $ -19.87M | $ -1.61M |
| Net Income | $ -7.99T | $ -10.61M | $ -24.96M | $ -29.15M | $ -938.73K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.50T | $ 1.12M | $ 3.15M | $ 12.26M | $ 194.21K |
| Total Assets | $ 5.60M | $ 2.71M | $ 5.89M | $ 16.42M | $ 351.81K |
| Total Debt | $ 301.66B | $ 854.70K | $ 4.41M | $ 12.75M | $ 4.27M |
| Net Debt | $ -3.20T | $ -268.91K | $ 1.26M | $ 483.42K | $ 4.08M |
| Total Liabilities | $ 10.10B | $ 3.36M | $ 9.91M | $ 24.58M | $ 7.01M |
| Stockholders' Equity | $ 3.71T | $ -322.86K | $ -4.03M | $ -8.16M | $ -6.44M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.50T | $ -10.78M | $ -17.89M | $ -8.24M | $ -1.25M |
| Operating Cash Flow | $ -7.50T | $ -10.78M | $ -17.89M | $ -8.24M | $ -1.25M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 4.50K | $ 0.00 | $ 183.40M |
| Financing Cash Flow | $ 9.88T | $ 8.76M | $ 8.77M | $ 20.31M | $ 1.10M |